SCHEMBL8307434

SCHEMBL8307434

O=C(c1ccccc1)c1ccc(Nc2ncnc3ccc(O)cc23)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.53
ERBB2 P04626 3/20 0.53
GRM4 Q14833 1/20 0.52
RAF1 P04049 4/20 0.51
BRAF P15056 4/20 0.51
MAPK14 Q16539 2/20 0.50
MAPK13 O15264 1/20 0.50
MAPK12 P53778 1/20 0.50
MAPK11 Q15759 1/20 0.50
KDM4E B2RXH2 1/20 0.50
GLA P06280 1/20 0.48
HTT P42858 1/20 0.48
ALK Q9UM73 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
LCK P06239 1/20 0.48
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305842 0.89 EGFR (0.60) EGFRERBB2GRM4MAPK14MAPK13
Hydrochloric Acid SCHEMBL8305253 0.84 EGFR (0.64) EGFRGRM4HTTALKABCG2
Hydrochloric Acid SCHEMBL8305110 0.84 EGFR (0.51) EGFRERBB2GRM4MAPK14MAPK13
SCHEMBL8305099 0.84 EGFR (0.48) EGFRERBB2RAF1BRAFALK
SCHEMBL8309634 0.83 HDAC3 (0.55) EGFRERBB2GRM4KDM4ELCK
SCHEMBL8309364 0.82 EGFR (0.70) EGFRERBB2MAPK14LCK
SCHEMBL8304875 0.82 AURKB (0.69) EGFRMAPK14
SCHEMBL5615221 0.82 CD38 (0.48) EGFRERBB2GRM4MAPK14MAPK13
SCHEMBL8783016 0.82 GRM4 (0.49) EGFRERBB2GRM4RAF1BRAF
Hydrochloric Acid SCHEMBL8307571 0.82 EGFR (0.69) EGFRERBB2MAPK14KDM4ELCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed